Amrize Ltd (AMRZ) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Amrize Ltd stock (AMRZ) is currently trading at $56.12. Amrize Ltd PE ratio is 25.85. Amrize Ltd PS ratio (Price-to-Sales) is 2.60. Analyst consensus price target for AMRZ is $67.12. WallStSmart rates AMRZ as Underperform.
- AMRZ PE ratio analysis and historical PE chart
- AMRZ PS ratio (Price-to-Sales) history and trend
- AMRZ intrinsic value — DCF, Graham Number, EPV models
- AMRZ stock price prediction 2025 2026 2027 2028 2029 2030
- AMRZ fair value vs current price
- AMRZ insider transactions and insider buying
- Is AMRZ undervalued or overvalued?
- Amrize Ltd financial analysis — revenue, earnings, cash flow
- AMRZ Piotroski F-Score and Altman Z-Score
- AMRZ analyst price target and Smart Rating
Amrize
📊 No data available
Try selecting a different time range
AMRZ Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Amrize Ltd (AMRZ)
AMRZ trades 119% above its Graham fair value of $26.88, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Amrize Ltd (AMRZ) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, peg ratio, institutional own.. Concerns around revenue growth and eps growth. Fundamentals are solid but monitor weak areas for improvement.
Amrize Ltd (AMRZ) Key Strengths (3)
Large-cap company with substantial market presence
Good growth relative to its price
54.22% held by institutions, strong professional interest
Supporting Valuation Data
Amrize Ltd (AMRZ) Areas to Watch (7)
Revenue declining -0.40%, a shrinking business
Earnings barely growing at 3.60%
Moderate profitability with room for improvement
Decent operational efficiency, solid but not exceptional
Revenue is fairly priced at 2.60x sales
Fairly priced relative to book value
Decent profitability, keeps $10 per $100 revenue
Supporting Valuation Data
Amrize Ltd (AMRZ) Detailed Analysis Report
Overall Assessment
This company scores 55/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 3 register as strengths (avg 8.3/10) while 7 fall into concern territory (avg 4.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Market Cap, PEG Ratio, Institutional Own.. Valuation metrics including PEG Ratio (1.40) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Return on Equity. Some valuation metrics including Price/Sales (2.60), Price/Book (2.19) suggest expensive pricing. Growth concerns include Revenue Growth at -0.40%, EPS Growth at 3.60%, which may limit upside. Profitability pressure is visible in Return on Equity at 10.20%, Operating Margin at 17.30%, Profit Margin at 10.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 10.20% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -0.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Market Cap, PEG Ratio) and negatives (Revenue Growth, EPS Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AMRZ Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AMRZ's Price-to-Sales ratio of 2.60x sits near its historical average of 2.59x (57th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 15% below its historical high of 3.05x set in Feb 2026, and 14% above its historical low of 2.27x in Sep 2025.
WallStSmart Analysis Synopsis
Data-driven financial summary for Amrize Ltd (AMRZ) · BASIC MATERIALS › BUILDING MATERIALS
The Big Picture
Amrize Ltd operates as a stable business with moderate growth and solid fundamentals. Revenue reached 11.8B with 40% decline year-over-year. Profit margins are thin at 10.0%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
ROE of 1020.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 1.6B in free cash flow and 1.8B in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 40% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Margin expansion: can Amrize Ltd push profit margins above 15% as the business scales?
Debt management: total debt of 6.9B is significantly higher than cash (826M). Monitor refinancing risk.
Sector dynamics: monitor BUILDING MATERIALS industry trends, competitive moves, and regulatory changes that could impact Amrize Ltd.
Bottom Line
Amrize Ltd offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:24:09 AM
About Amrize Ltd(AMRZ)
NYSE
BASIC MATERIALS
BUILDING MATERIALS
USA
Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, striving to transform healthcare delivery through advanced technologies and data-driven solutions. With a strong emphasis on enhancing patient outcomes and increasing healthcare accessibility, Amrize engages in extensive research and development to address the growing demand for scalable health solutions. The company’s strategic initiatives position it to play a pivotal role in the evolving landscape of healthcare, making it a critical player in the advancement of modern healthcare systems.